Effect of growth hormone on high plasma levels of glucagon-like peptide-1 (GLP-1) in hypophysectomized rats

被引:4
|
作者
Tateishi, K
Kitayama, N
Ishikawa, H
Mitsudome, A
Hirose, S
机构
[1] Fukuoka Univ, Sch Med, Dept Biochem, Jonan Ku, Fukuoka 8140180, Japan
[2] Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka 81401, Japan
[3] JCR Pharmaceut Co Ltd, Kobe, Hyogo, Japan
关键词
hypophysectomized rat; plasma GLP-1; GH; oral glucose tolerance test;
D O I
10.1055/s-2002-34994
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fasting plasma GLP-1 levels were significantly higher in hypophysectomized (hypox) rats (n=6) than in intact (normal) rats (n=7) (54.3+/-5.2 vs. 33.3+/-2.4 pmol/L, p<0.001). To examine the influence of pituitary hormones on plasma GLP-1 levels, concentrations of plasma glucose, insulin and GLP-1 after an oral glucose load to hypox rats that were given either rat growth hormone (rGH) (n=7), cortisol and thyroxine (n=7) or no substitution (n=6) were compared with those of normal rats (n=7). Plasma glucose levels in the fasting state and after the glucose ingestion were significantly lower in hypox rats, but the patterns were different from those in normal rats. Insulin levels both in the fasting state and after the glucose ingestion were significantly decreased in hypox rats and the fasting and total GLP-1 levels were significantly increased in those rats. rGH substitution significantly increased the total insulin levels in hypox rats and decreased the fasting and total GLP-1 levels closely to levels in normal rats, while substitution with cortisol and thyroxine failed to introduce such a significant effect. These results suggested that secretion of GLP-1 might be influenced by the function of GH.
引用
收藏
页码:361 / 363
页数:3
相关论文
共 50 条
  • [21] Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Cardiac Disorders
    Wroge, Jamie
    Williams, Nancy Toedter
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (12) : 1041 - 1050
  • [22] STRUCTURE OF HUMAN GLP-1(GLUCAGON-LIKE PEPTIDE-1) CONTAINING PEPTIDES
    ORSKOV, C
    KOFOD, H
    RABENHOJ, L
    WETTERGREN, A
    HOLST, JJ
    DIABETOLOGIA, 1992, 35 : A109 - A109
  • [23] Glucagon-like peptide-1 [GLP-1]: A gut hormone on its way from bench to beside
    Goke, B
    Fehmann, HC
    Schirra, J
    Hareter, A
    Goke, R
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1997, 35 (04): : 285 - 294
  • [24] Potent enterogastrone actions of the insulinotropic hormone, glucagon-like peptide-1 (GLP-1): Mechanisms of action
    Holst, JJ
    Wojdemann, M
    Andre, W
    Lars, R
    DIABETES, 1999, 48 : A21 - A22
  • [25] Degradation of the Incretin Hormone Glucagon-Like Peptide-1 (GLP-1) by Enterococcus faecalis Metalloprotease GelE
    LeValley, Stephanie L.
    Tomaro-Duchesneau, Catherine
    Britton, Robert A.
    MSPHERE, 2020, 5 (01):
  • [26] Hepatic elimination and first-pass-effect of glucagon-like peptide-1 (GLP-1)
    Sandel, JP
    Greischel, A
    Roth, W
    TIERAERZTLICHE PRAXIS AUSGABE KLEINTIERE HEIMTIERE, 2006, 34 (02): : 132 - 137
  • [27] Glucagon-like peptide 1 (GLP-1) and eating
    Gutzwiller, JP
    Degen, L
    Heuss, L
    Beglinger, C
    PHYSIOLOGY & BEHAVIOR, 2004, 82 (01) : 17 - 19
  • [28] Active glucagon-like peptide-1 (GLP-1): Storage of human plasma and stability over time
    Di Marino, Lucrezia
    Griffo, Ettore
    Maione, Simona
    Mirabella, Martina
    CLINICA CHIMICA ACTA, 2011, 412 (17-18) : 1693 - 1694
  • [29] EFFECT OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANTIBODIES ON GLUCOSE-INDUCED INSULIN-SECRETION IN RATS
    SHIMA, K
    OHBOSHI, C
    HIROTA, M
    BIOMEDICAL RESEARCH-TOKYO, 1989, 10 (05): : 417 - 422
  • [30] Glucagon-like peptide-1 (GLP-1) promotes the growth of the biliary tree in the normal and in the cholestatic rat
    Marzioni, M.
    Alpini, G.
    Saccomanno, S.
    Candelaresi, C.
    Glaser, S.
    Rychlicki, C.
    Francis, H.
    Trozzi, L.
    Venter, J.
    Reichenbach, R.
    Benedetti, A.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S43 - S43